Revisiting the PLASMIC score and the future of ADAMTS13 prediction
Mehmet Baysal, Ahmet Emre Eşkazan · 2026
Read Revisiting the PLASMIC score and the future of ADAMTS13 prediction by Mehmet Baysal, Ahmet Emre Eşkazan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13400860.txt.
Description
Baysal and Eşkazan revisit, in a 2026 letter, the PLASMIC score used to predict severe ADAMTS13 deficiency in thrombotic thrombocytopenic purpura, a rare blood emergency where fast prediction guides plasma exchange. They discuss a recent multicenter reevaluation by Singh and colleagues, which exposed a diagnostic gap in older patients. Sensitivity fell to 62 percent among patients aged 60 and over, a vulnerable group in whom comorbidities can confound the score's traditional parameters.
Working through the score item by item, the letter endorses simplification, singling out mean corpuscular volume as the weakest link. The authors note both PLASMIC and its predecessor, the Bentley score, still lack validation in pediatric immune-mediated disease and pregnancy-associated microangiopathies. They argue the field should shift toward nuanced, data-driven models rather than fixed point scores. Retrospective single-center studies, they concede, show comparable utility to PLASMIC despite smaller cohorts, sharpening the case for redevelopment.
Catalog record
| CREATOR | Mehmet Baysal, Ahmet Emre Eşkazan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |